Evaluates migraine progression definitions using headache days and MIDAS scores, indicating disease severity changes.
Using the CaMEO study, we evaluated 2 different definitions of migraine disease progression, based on changes in either monthly headache days (MHDs) or in Migraine Disability Assessment Scale (MIDAS) scores.
No takes yet. Share an insight, caveat, or question.
Lipton et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: